Filing Details
- Accession Number:
- 0001209191-22-052218
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-10-04 16:19:28
- Reporting Period:
- 2022-09-30
- Accepted Time:
- 2022-10-04 16:19:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1600847 | Gamida Cell Ltd. | GMDA | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1947032 | L. Abigail Jenkins | C/O Gamida Cell Ltd. 116 Huntington Avenue Boston MA 02116 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2022-09-30 | 16,129 | $1.55 | 266,129 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reporting person purchased ordinary shares of the Issuer at a price of $1.55 per share in an underwritten public offering by the Issuer, which closed on September 30, 2022.
Billionaire Hedge Funds
